How the ESCRT-III-like protein Vipp1 assembles polymeric super-structures to mitigate membrane stress
How the ESCRT-III-like protein Vipp1 assembles polymeric super-structures to mitigate membrane stress
批准号:
BB/W008181/1
负责人:
Harry Low
金额:
$89.01万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2022
资助国家:
英国
项目状态:
未结题
起止时间:
2022 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
In all living systems, membranes are used to separate the inside of the cell from the outside environment. Membranes are also used to shape cells internally so that different areas can form specialist compartments with distinct roles. In cells, membranes are dynamic requiring continual remodelling for many processes including cell division for growth or membrane trafficking for the movement of cargo. In order to remodel the membrane, cells have evolved specialist protein families to undertake this physical work.One of the most important membrane remodelling families are ESCRT-III proteins. They are universal in eukaryotes (cells like our own). ESCRT-III proteins are so ancient that they have ancestors in some archaea from which eukaryotes later evolved. Recently, in an exciting discovery, we showed that ESCRT-III proteins also exist in bacteria (PspA) and in cyanobacteria (Vipp1). This is important as it showed that an ESCRT-III-like protein was present in the last universal common ancestor of all cells (LUCA) and that all evolutionary domains including bacteria, archaea and eukaryotes have depended on ESCRT-III-like proteins to shape membrane since the earliest attempts at life.ESCRT-III-like proteins undertake many essential functions. In humans, they are essential for the final separation of dividing cells and membrane repair. They are also implicated in many diseases including viral invasion, bacterial infection, cancer and neurodegeneration such as dementia and Huntington's disease. Due to its role in membrane protection, PspA is a driver of anti-microbial resistance (AMR) and bacterial pathogenesis.In this proposal we study Vipp1, which is found in all cyanobacteria, algae and plants. We know that Vipp1 is important as gene knockout is usually lethal. This is due to abnormal formation of the thylakoid membranes where photosynthesis is undertaken. What we still do not know is what Vipp1 does in the cell and what its membrane remodelling duties are. Currently, we think that Vipp1 proteins assemble together to build superstructures that include rings, helical filaments and flat scaffolds that somehow shape and support membrane possibly in regions of high stress where the integrity of the membrane is physically or chemically threatened. The overall goal of this proposal is to understand the mechanism for how Vipp1 builds these superstructures and uses them to do mechanical work on the membrane. Vipp1 also represents a tractable system which can show us the universal mechanistic principles underlying how PspA and more complicated ESCRT-III systems work and cause disease. Finally, Vipp1 modification in engineered cyanobacteria facilitates high yields of fatty acids for both nutritional and anti-inflammatory use. In future biotechnological application, similar Vipp1 modification may facilitate the production of other useful molecules such as biofuels in cyanobacteria.Aims:1) to understand how Vipp1 builds and switches between different superstructures so as to shape, stabilise and repair membrane. Specifically, a powerful form of electron microscopy will allow us to visualize the precise position of the Vipp1 atoms within helical filaments so we can learn about their 3D structure and chemistry. 2D planar filament architecture when attached to membrane will be deduced at lower resolution. Understanding how Vipp1 builds different structural forms lies at the heart of its membrane remodelling capabilities.2) to explore how Vipp1 superstructures have the ability to sculpt membrane in a simplified 'in vitro' environment. By mixing Vipp1 with both membrane and Vipp1 binding proteins (VBPs), we aim to reconstitute any membrane cutting, joining or stabilising events that may represent what Vipp1 does in the cell.3) to find other proteins in the cell that attach to Vipp1 and changes how it functions. Such VBPs may shift the way Vipp1 builds or disassembles superstructures and how it remodels membrane.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1101/2023.09.26.559607
发表时间:
2023-09
期刊:
bioRxiv
影响因子:
--
作者:
[Souvik Naskar;Andrea Merino;Javier Espadas;Jayanti Singh;Aurélien Roux;A. Colom;Harry H Low]
通讯作者:
Souvik Naskar;Andrea Merino;Javier Espadas;Jayanti Singh;Aurélien Roux;A. Colom;Harry H Low
国内基金
海外基金
登录
查看更多内容
猪流行性腹泻病毒通过宿主ESCRT组分
ALIX介导病毒双膜囊泡形成的分子机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:陈熊男
-
依托单位:
硫化砷靶向VPS4B-ESCRT-III调控自噬溶酶体通路逆转三阴性乳腺癌顺铂耐药性的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:陈思宇
-
依托单位:
基于GSDMD-ESCRT信号通路探讨结直肠癌发病机制及参苓白术散干预机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:30.0万元
-
批准年份:2024
-
负责人:陈菊
-
依托单位:
UEV-Vps23介导阿斯加德古菌ESCRT泛素化过程的分子机制研究
-
批准号:32370004
-
项目类别:面上项目
-
资助金额:50万元
-
批准年份:2023
-
负责人:卢中一
-
依托单位:
PRRSV利用ESCRT-II亚基EAP20促进复制转录复合体形成的分子机制研究
-
批准号:32302852
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:张龙祥
-
依托单位:
植物ESCRT亚基TSG101调控病毒细胞内移动的分子机制研究
-
批准号:32302318
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:葛林豪
-
依托单位:
脑缺血/再灌注时ESCRT-III抗神经细胞铁自噬-铁死亡机制及药物干预研究
-
批准号:2023JJ40514
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:田静
-
依托单位:
ACTG1经ERK-ESCRT信号通路促胰腺癌进展的研究
-
批准号:CSTB2023NSCQ-MSX0182
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2023
-
负责人:唐艺宸
-
依托单位:
GRB2/Clathrin/ESCRT介导的内吞、运输及溶酶体降解在CD7 CAR-T细胞诱导T细胞CD7阴性表达的机制研究
-
批准号:82270234
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:胡永仙
-
依托单位:
ESCRT介导狂犬病毒出芽的在体结构研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:54万元
-
批准年份:2022
-
负责人:张岩
-
依托单位: